Muscular dystrophy (MD) is a group of genetic disorders characterized by progressive muscle weakening and loss, often leading to significant disability and a reduced quality of life. While MD has no definitive cure, emerging therapies, particularly stem cell therapy, offer hope. Stem cell therapy is a field of regenerative medicine that leverages the unique properties of stem cells to repair or replace damaged tissues.
Interstitial Lung Disease can occur due to long-term exposure to hazardous substances, such as asbestos or coal dust, or it could be due to an auto-immune disease like rheumatoid arthritis. As soon as lung scarring takes place, it's usually irreversible.
Arthritis Knee is the most common disease of the joints and a leading cause of chronic disability, especially in the aged population. It occurs due to long standing wear and tear of the joint, which leads to cartilage damage.Stemcellindia Provides one of the best stem cell therapy in arthritis knee at reasonable price in India.
Arthritis Knee is the most common disease of the joints and a leading cause of chronic disability, especially in the aged population. It occurs due to long standing wear and tear of the joint, which leads to cartilage damage. Stemcellindia Provides one of the best stem cell therapy in arthritis knee at reasonable price in India.
Arthritis Knee is the most common disease of the joints and a leading cause of chronic disability, especially in the aged population. It occurs due to long standing wear and tear of the joint, which leads to cartilage damage. Stemcellindia Provides one of the best stem cell therapy in arthritis knee at reasonable price in India
Patients with DMD are not able to produce a protein known as dystrophin. Hence, a variety of new medications are being developed to replace dystrophin. Moreover, new therapies aim to repair muscle damage caused due to the absence of dystrophin. However, delay in diagnosis and the high cost of treatment and drugs are some of the factors restricting the growth of the market.
As per the report by Persistence Market Research (PMR), the global duchenne muscular dystrophy market is expected to experience strong growth. The market is also estimated to expand at a CAGR of 48.3% during the forecast period. The global duchenne muscular dystrophy market is estimated to bring in US$ 10,664.5 million revenue by the end of 2026.